_version_ 1784576103461945344
author Anguiano-Álvarez, Víctor Manuel
Maza-Larrea, José Antonio
Rosado-Hernández, Francisco Javier
Rojas-Velasco, Gustavo
Izaguirre-Ávila, Raúl
author_facet Anguiano-Álvarez, Víctor Manuel
Maza-Larrea, José Antonio
Rosado-Hernández, Francisco Javier
Rojas-Velasco, Gustavo
Izaguirre-Ávila, Raúl
author_sort Anguiano-Álvarez, Víctor Manuel
collection PubMed
description
format Online
Article
Text
id pubmed-8478626
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-84786262021-10-09 Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient Anguiano-Álvarez, Víctor Manuel Maza-Larrea, José Antonio Rosado-Hernández, Francisco Javier Rojas-Velasco, Gustavo Izaguirre-Ávila, Raúl Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021-09-30 2021-09-30 /pmc/articles/PMC8478626/ /pubmed/34400588 http://dx.doi.org/10.5045/br.2021.2020245 Text en © 2021 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letters to the Editor
Anguiano-Álvarez, Víctor Manuel
Maza-Larrea, José Antonio
Rosado-Hernández, Francisco Javier
Rojas-Velasco, Gustavo
Izaguirre-Ávila, Raúl
Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
title Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
title_full Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
title_fullStr Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
title_full_unstemmed Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
title_short Ruxolitinib-induced extreme thrombocytosis in a COVID-19 patient
title_sort ruxolitinib-induced extreme thrombocytosis in a covid-19 patient
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478626/
https://www.ncbi.nlm.nih.gov/pubmed/34400588
http://dx.doi.org/10.5045/br.2021.2020245
work_keys_str_mv AT anguianoalvarezvictormanuel ruxolitinibinducedextremethrombocytosisinacovid19patient
AT mazalarreajoseantonio ruxolitinibinducedextremethrombocytosisinacovid19patient
AT rosadohernandezfranciscojavier ruxolitinibinducedextremethrombocytosisinacovid19patient
AT rojasvelascogustavo ruxolitinibinducedextremethrombocytosisinacovid19patient
AT izaguirreavilaraul ruxolitinibinducedextremethrombocytosisinacovid19patient